Correction of temporal wasting using calcium hydroxylapatite with integral lidocaine: An underused procedure for enhancing overall facial appearance

Background Hollowing of the temple area is an early sign of aging that is often overlooked, but when corrected, can lead to significant subject and physician satisfaction. Aims To assess physician and subject awareness of the impact of temporal hollowing on appearance and to evaluate treatment satis...

Full description

Saved in:
Bibliographic Details
Published inJournal of cosmetic dermatology Vol. 20; no. 1; pp. 62 - 66
Main Author Barbarino, Sheila C.
Format Journal Article
LanguageEnglish
Published England 01.01.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Hollowing of the temple area is an early sign of aging that is often overlooked, but when corrected, can lead to significant subject and physician satisfaction. Aims To assess physician and subject awareness of the impact of temporal hollowing on appearance and to evaluate treatment satisfaction following injection of calcium hydroxylapatite with integral lidocaine (CaHA(+)). Patients/Methods Subjects with temporal depression grade ≥2 on a validated Temple Hollowing Scale were recruited. CaHA(+) was injected supraperiosteally using a bolus technique. Photographs were taken prior to treatment and 30 days, and graded by three evaluating physicians using the Global Aesthetic Improvement Scale (GAIS) and Temple Hollowing Scale. The same physicians estimated subjects' age before and after treatment. Photographs were graded by patients as part of a satisfaction questionnaire. Results The study enrolled 10 subjects aged 32‐68 years old. Physician GAIS scores of subject appearance at 1 month were rated as “very much improved” in 80% and “much improved” in 20% of subjects. Temple hollows were graded as 1 after treatment in 90% of subjects. Following blinded review of patients' true ages, estimates for subjects' perceived age were on average 4 years younger than their actual age. Most subjects had not been aware of temple hollowing prior to treatment, but nine out of 10 were very to extremely satisfied with results, and all were willing to repeat treatment. No treatment complications were observed. Conclusion Treatment of the temple area can have a dramatic aesthetic effect and should not be neglected when addressing facial rejuvenation. CaHA(+) is an effective and well‐tolerated product for use in the temple area and is associated with a high degree of subject and physician satisfaction.
AbstractList Hollowing of the temple area is an early sign of aging that is often overlooked, but when corrected, can lead to significant subject and physician satisfaction.BACKGROUNDHollowing of the temple area is an early sign of aging that is often overlooked, but when corrected, can lead to significant subject and physician satisfaction.To assess physician and subject awareness of the impact of temporal hollowing on appearance and to evaluate treatment satisfaction following injection of calcium hydroxylapatite with integral lidocaine (CaHA(+)).AIMSTo assess physician and subject awareness of the impact of temporal hollowing on appearance and to evaluate treatment satisfaction following injection of calcium hydroxylapatite with integral lidocaine (CaHA(+)).Subjects with temporal depression grade ≥2 on a validated Temple Hollowing Scale were recruited. CaHA(+) was injected supraperiosteally using a bolus technique. Photographs were taken prior to treatment and 30 days, and graded by three evaluating physicians using the Global Aesthetic Improvement Scale (GAIS) and Temple Hollowing Scale. The same physicians estimated subjects' age before and after treatment. Photographs were graded by patients as part of a satisfaction questionnaire.PATIENTS/METHODSSubjects with temporal depression grade ≥2 on a validated Temple Hollowing Scale were recruited. CaHA(+) was injected supraperiosteally using a bolus technique. Photographs were taken prior to treatment and 30 days, and graded by three evaluating physicians using the Global Aesthetic Improvement Scale (GAIS) and Temple Hollowing Scale. The same physicians estimated subjects' age before and after treatment. Photographs were graded by patients as part of a satisfaction questionnaire.The study enrolled 10 subjects aged 32-68 years old. Physician GAIS scores of subject appearance at 1 month were rated as "very much improved" in 80% and "much improved" in 20% of subjects. Temple hollows were graded as 1 after treatment in 90% of subjects. Following blinded review of patients' true ages, estimates for subjects' perceived age were on average 4 years younger than their actual age. Most subjects had not been aware of temple hollowing prior to treatment, but nine out of 10 were very to extremely satisfied with results, and all were willing to repeat treatment. No treatment complications were observed.RESULTSThe study enrolled 10 subjects aged 32-68 years old. Physician GAIS scores of subject appearance at 1 month were rated as "very much improved" in 80% and "much improved" in 20% of subjects. Temple hollows were graded as 1 after treatment in 90% of subjects. Following blinded review of patients' true ages, estimates for subjects' perceived age were on average 4 years younger than their actual age. Most subjects had not been aware of temple hollowing prior to treatment, but nine out of 10 were very to extremely satisfied with results, and all were willing to repeat treatment. No treatment complications were observed.Treatment of the temple area can have a dramatic aesthetic effect and should not be neglected when addressing facial rejuvenation. CaHA(+) is an effective and well-tolerated product for use in the temple area and is associated with a high degree of subject and physician satisfaction.CONCLUSIONTreatment of the temple area can have a dramatic aesthetic effect and should not be neglected when addressing facial rejuvenation. CaHA(+) is an effective and well-tolerated product for use in the temple area and is associated with a high degree of subject and physician satisfaction.
Background Hollowing of the temple area is an early sign of aging that is often overlooked, but when corrected, can lead to significant subject and physician satisfaction. Aims To assess physician and subject awareness of the impact of temporal hollowing on appearance and to evaluate treatment satisfaction following injection of calcium hydroxylapatite with integral lidocaine (CaHA(+)). Patients/Methods Subjects with temporal depression grade ≥2 on a validated Temple Hollowing Scale were recruited. CaHA(+) was injected supraperiosteally using a bolus technique. Photographs were taken prior to treatment and 30 days, and graded by three evaluating physicians using the Global Aesthetic Improvement Scale (GAIS) and Temple Hollowing Scale. The same physicians estimated subjects' age before and after treatment. Photographs were graded by patients as part of a satisfaction questionnaire. Results The study enrolled 10 subjects aged 32‐68 years old. Physician GAIS scores of subject appearance at 1 month were rated as “very much improved” in 80% and “much improved” in 20% of subjects. Temple hollows were graded as 1 after treatment in 90% of subjects. Following blinded review of patients' true ages, estimates for subjects' perceived age were on average 4 years younger than their actual age. Most subjects had not been aware of temple hollowing prior to treatment, but nine out of 10 were very to extremely satisfied with results, and all were willing to repeat treatment. No treatment complications were observed. Conclusion Treatment of the temple area can have a dramatic aesthetic effect and should not be neglected when addressing facial rejuvenation. CaHA(+) is an effective and well‐tolerated product for use in the temple area and is associated with a high degree of subject and physician satisfaction.
Hollowing of the temple area is an early sign of aging that is often overlooked, but when corrected, can lead to significant subject and physician satisfaction. To assess physician and subject awareness of the impact of temporal hollowing on appearance and to evaluate treatment satisfaction following injection of calcium hydroxylapatite with integral lidocaine (CaHA(+)). Subjects with temporal depression grade ≥2 on a validated Temple Hollowing Scale were recruited. CaHA(+) was injected supraperiosteally using a bolus technique. Photographs were taken prior to treatment and 30 days, and graded by three evaluating physicians using the Global Aesthetic Improvement Scale (GAIS) and Temple Hollowing Scale. The same physicians estimated subjects' age before and after treatment. Photographs were graded by patients as part of a satisfaction questionnaire. The study enrolled 10 subjects aged 32-68 years old. Physician GAIS scores of subject appearance at 1 month were rated as "very much improved" in 80% and "much improved" in 20% of subjects. Temple hollows were graded as 1 after treatment in 90% of subjects. Following blinded review of patients' true ages, estimates for subjects' perceived age were on average 4 years younger than their actual age. Most subjects had not been aware of temple hollowing prior to treatment, but nine out of 10 were very to extremely satisfied with results, and all were willing to repeat treatment. No treatment complications were observed. Treatment of the temple area can have a dramatic aesthetic effect and should not be neglected when addressing facial rejuvenation. CaHA(+) is an effective and well-tolerated product for use in the temple area and is associated with a high degree of subject and physician satisfaction.
Author Barbarino, Sheila C.
Author_xml – sequence: 1
  givenname: Sheila C.
  orcidid: 0000-0002-8367-8663
  surname: Barbarino
  fullname: Barbarino, Sheila C.
  email: sheila.barbarino@gmail.com
  organization: Barbarino Surgical Arts
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32441877$$D View this record in MEDLINE/PubMed
BookMark eNp9kctu3CAUhlGVqrm0mz5AxDKqNAkYg-3sommbiyJlk66tM3CcIcLgAO503qMPXLuTZlFFYQFIfN-vI_5DsueDR0I-c3bKp3X2GLQ55UIy-Y4c8LISi4IrufdyF2yfHKb0yBivGi4_kH1RlCWvq-qA_F6GGFFnGzwNHc3YDyGCoxtI2foHOqZ51-C0HXu63poYfm0dDJBtRrqxeU2tz_gwO86aoMF6PKcXno7eYBwTGjrEoNGMEWkXIkW_Bq_n1PATJ83RDrSddBgGhDi94UfyvgOX8NPzeUR-fP92v7xa3N5dXi8vbhdaFI1cGLXiqlaSq5U2FdRGKcNk2ehC1FBrZNA1qtSyKSXvmsoU0HHRiNIUqpEGlDgiJ7vcacKnEVNue5s0Ogcew5jaomRKsLpSfEKPn9Fx1aNph2h7iNv2309OwJcdoGNIKWL3gnDWzjW1c03t35ommP0Ha5thLiFHsO51he-UjXW4fSO8vblbft05fwDr_6fc
CitedBy_id crossref_primary_10_1093_asj_sjab035
crossref_primary_10_3390_jcm13061686
crossref_primary_10_1111_jocd_16450
crossref_primary_10_3390_cosmetics11050165
crossref_primary_10_1097_GOX_0000000000006400
crossref_primary_10_1007_s00266_024_04429_9
Cites_doi 10.1097/01.prs.0000234847.36020.52
10.1097/PRS.0b013e31824a2e21
10.1177/1090820X10391214
10.1111/dsu.12362
10.1016/j.ejfs.2014.07.006
10.1016/j.cps.2012.09.001
10.1097/DSS.0000000000001268
10.1097/DSS.0000000000000848
10.1111/jocd.12437
10.1177/1090820X10374099
10.1055/s-0036-1586497
10.1097/PRS.0000000000001752
10.1111/j.1468-3083.2006.01518.x
ContentType Journal Article
Copyright 2020 Wiley Periodicals LLC
2020 Wiley Periodicals LLC.
Copyright_xml – notice: 2020 Wiley Periodicals LLC
– notice: 2020 Wiley Periodicals LLC.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/jocd.13505
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1473-2165
EndPage 66
ExternalDocumentID 32441877
10_1111_jocd_13505
JOCD13505
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
1OC
24P
29K
31~
33P
36B
3SF
4.4
50Y
50Z
52M
52O
52T
52U
52V
52W
53G
5GY
5HH
5VS
702
7PT
7X7
8-0
8-1
8-3
8-4
8-5
8FI
8FJ
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANHP
AAONW
AASGY
AAXRX
AAZKR
ABCUV
ABDBF
ABJNI
ABPVW
ABUWG
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCMX
ACCZN
ACGFS
ACMXC
ACPOU
ACRPL
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADPDF
ADXAS
ADZCM
ADZMN
AEEZP
AEGXH
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFEBI
AFGKR
AFKRA
AFPWT
AFZJQ
AIACR
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BENPR
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
C45
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
D-I
DCZOG
DPXWK
DRFUL
DRMAN
DRSTM
EAD
EAP
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F21
F5P
FEDTE
FUBAC
FYUFA
G-S
G.N
GODZA
H.X
HF~
HMCUK
HVGLF
HZ~
IHE
KBYEO
LATKE
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
N04
N05
NF~
O66
O9-
OIG
OVD
OVEED
P2P
P2W
P2X
P2Z
P4B
P4D
PIMPY
Q.N
QB0
R.K
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
UKHRP
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WVDHM
YFH
YUY
ZZTAW
~IA
~WT
AAYXX
AGQPQ
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7X8
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
ID FETCH-LOGICAL-c3295-d6b1686516bcd7a8d66d0549c238a8ce0af964c59451f97d2af13934d2695da63
ISSN 1473-2130
1473-2165
IngestDate Fri Jul 11 04:31:01 EDT 2025
Wed Feb 19 02:29:43 EST 2025
Thu Apr 24 22:51:36 EDT 2025
Tue Jul 01 02:37:35 EDT 2025
Wed Jan 22 16:30:55 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords facial rejuvenation
aging
calcium hydroxylapatite
temple area
lidocaine
Language English
License 2020 Wiley Periodicals LLC.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3295-d6b1686516bcd7a8d66d0549c238a8ce0af964c59451f97d2af13934d2695da63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-8367-8663
PMID 32441877
PQID 2406308761
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_2406308761
pubmed_primary_32441877
crossref_primary_10_1111_jocd_13505
crossref_citationtrail_10_1111_jocd_13505
wiley_primary_10_1111_jocd_13505_JOCD13505
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate January 2021
2021-01-00
2021-Jan
20210101
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – month: 01
  year: 2021
  text: January 2021
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of cosmetic dermatology
PublicationTitleAlternate J Cosmet Dermatol
PublicationYear 2021
References 2018; 17
2015; 5
2006; 20
2013; 39
2015; 136
2013; 12
2013; 40
2011; 31
2016; 32
2016; 42
2018; 44
2006; 118
2015; 8
2016; 15
2010; 30
2012; 129
e_1_2_7_6_1
e_1_2_7_5_1
Meland M (e_1_2_7_17_1) 2016; 15
e_1_2_7_4_1
e_1_2_7_9_1
e_1_2_7_7_1
e_1_2_7_18_1
Lupo MP (e_1_2_7_3_1) 2016; 15
Moradi A (e_1_2_7_8_1) 2013; 12
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_14_1
e_1_2_7_13_1
e_1_2_7_12_1
e_1_2_7_10_1
Van Loghem JV (e_1_2_7_19_1) 2015; 8
Pavicic T (e_1_2_7_11_1) 2013; 12
References_xml – volume: 136
  start-page: 44S
  issue: 5 suppl
  year: 2015
  end-page: 48S
  article-title: Newer understanding of specific anatomic targets in the aging face as applied to injectables: aging changes in the craniofacial skeleton and facial ligaments
  publication-title: Plast Reconstr Surg
– volume: 39
  start-page: 1895
  issue: 12
  year: 2013
  end-page: 1902
  article-title: Quantifying soft tissue loss in facial aging: a study in women using magnetic resonance imaging
  publication-title: Dermatol Surg
– volume: 40
  start-page: 77
  year: 2013
  end-page: 89
  article-title: Esthetic rejuvenation of the temple
  publication-title: Clin Plast Surg
– volume: 20
  start-page: 17
  issue: suppl 1
  year: 2006
  end-page: 21
  article-title: Poly‐L‐lactic acid: consultation on the injection techniques
  publication-title: J Eur Acad Dermatol Venereol
– volume: 31
  start-page: 89
  year: 2011
  end-page: 94
  article-title: A technique for filling the temples with highly diluted hyaluronic acid: the “dilution solution”
  publication-title: Aesthet Surg J
– volume: 5
  start-page: 46
  issue: 2
  year: 2015
  end-page: 56
  article-title: Analysis of facial soft tissue changes with aging and their effects on facial morphology: a forensic perspective
  publication-title: Egypt J Foren Sci
– volume: 12
  start-page: 470
  issue: 4
  year: 2013
  end-page: 475
  article-title: A 12‐month, prospective, evaluator‐blinded study of small gel particle hyaluronic acid filler in the correction of temporal fossa volume loss
  publication-title: J Drugs Dermatol
– volume: 12
  start-page: 996
  year: 2013
  end-page: 1002
  article-title: Calcium hydroxylapatite filler: an overview of safety and tolerability
  publication-title: J Drugs Dermatol
– volume: 30
  start-page: 428
  year: 2010
  end-page: 433
  article-title: Orbitofacial rejuvenation of temple hollowing with Perlane injectable filler
  publication-title: Aesthet Surg J
– volume: 118
  start-page: 34S
  year: 2006
  end-page: 45S
  article-title: Prospective, open‐label, 18‐month trial of calcium hydroxylapatite (Radiesse) for facial soft‐tissue augmentation in patients with human immunodeficiency virus‐associated lipoatrophy: one year durability
  publication-title: Plast Reconstr Surg
– volume: 17
  start-page: 39
  issue: 1
  year: 2018
  end-page: 46
  article-title: Sensitivity of aspiration as a safety test before injection of soft tissue fillers
  publication-title: J Cosmet Dermatol
– volume: 129
  start-page: 1200
  year: 2012
  end-page: 1207
  article-title: A guide to interpreting a study of patient‐reported outcomes
  publication-title: Plast Reconstr Surg
– volume: 15
  start-page: 1107
  issue: 9
  year: 2016
  end-page: 1110
  article-title: Rheological properties of calcium hydroxylapatite with integral lidocaine
  publication-title: J Drugs Dermatol
– volume: 44
  start-page: 93
  issue: 1
  year: 2018
  end-page: 100
  article-title: Pilot study examining the safety and efficacy of calcium hydroxylapatite filler with integral lidocaine over a 12‐month period to correct temporal fossa volume loss
  publication-title: Dermatol Surg
– volume: 42
  start-page: S203
  year: 2016
  end-page: S210
  article-title: Development and validation of a photonumeric scale for evaluation of volume deficit of the temple
  publication-title: Dermatol Surg
– volume: 15
  start-page: 1151
  issue: 9
  year: 2016
  end-page: 1157
  article-title: Tox outside the box: off‐label aesthetic uses of botulinum toxin
  publication-title: J Drugs Dermatol
– volume: 32
  start-page: 520
  issue: 5
  year: 2016
  end-page: 531
  article-title: Solid implants in facial plastic surgery: potential complications and how to prevent them
  publication-title: Facial Plast Surg
– volume: 8
  start-page: 38
  issue: 1
  year: 2015
  end-page: 49
  article-title: Calcium hydroxylapatite: over a decade of clinical experience
  publication-title: J Clin Aesthet Dermatol
– volume: 12
  start-page: 470
  issue: 4
  year: 2013
  ident: e_1_2_7_8_1
  article-title: A 12‐month, prospective, evaluator‐blinded study of small gel particle hyaluronic acid filler in the correction of temporal fossa volume loss
  publication-title: J Drugs Dermatol
– ident: e_1_2_7_12_1
  doi: 10.1097/01.prs.0000234847.36020.52
– ident: e_1_2_7_16_1
  doi: 10.1097/PRS.0b013e31824a2e21
– ident: e_1_2_7_7_1
  doi: 10.1177/1090820X10391214
– volume: 8
  start-page: 38
  issue: 1
  year: 2015
  ident: e_1_2_7_19_1
  article-title: Calcium hydroxylapatite: over a decade of clinical experience
  publication-title: J Clin Aesthet Dermatol
– ident: e_1_2_7_15_1
  doi: 10.1111/dsu.12362
– ident: e_1_2_7_4_1
  doi: 10.1016/j.ejfs.2014.07.006
– ident: e_1_2_7_5_1
  doi: 10.1016/j.cps.2012.09.001
– ident: e_1_2_7_13_1
  doi: 10.1097/DSS.0000000000001268
– ident: e_1_2_7_14_1
  doi: 10.1097/DSS.0000000000000848
– ident: e_1_2_7_18_1
  doi: 10.1111/jocd.12437
– volume: 15
  start-page: 1151
  issue: 9
  year: 2016
  ident: e_1_2_7_3_1
  article-title: Tox outside the box: off‐label aesthetic uses of botulinum toxin
  publication-title: J Drugs Dermatol
– volume: 12
  start-page: 996
  year: 2013
  ident: e_1_2_7_11_1
  article-title: Calcium hydroxylapatite filler: an overview of safety and tolerability
  publication-title: J Drugs Dermatol
– volume: 15
  start-page: 1107
  issue: 9
  year: 2016
  ident: e_1_2_7_17_1
  article-title: Rheological properties of calcium hydroxylapatite with integral lidocaine
  publication-title: J Drugs Dermatol
– ident: e_1_2_7_6_1
  doi: 10.1177/1090820X10374099
– ident: e_1_2_7_10_1
  doi: 10.1055/s-0036-1586497
– ident: e_1_2_7_2_1
  doi: 10.1097/PRS.0000000000001752
– ident: e_1_2_7_9_1
  doi: 10.1111/j.1468-3083.2006.01518.x
SSID ssj0017915
Score 2.2466385
Snippet Background Hollowing of the temple area is an early sign of aging that is often overlooked, but when corrected, can lead to significant subject and physician...
Hollowing of the temple area is an early sign of aging that is often overlooked, but when corrected, can lead to significant subject and physician...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 62
SubjectTerms Adult
Aged
aging
Calcium
calcium hydroxylapatite
Child, Preschool
Cosmetic Techniques
Durapatite
facial rejuvenation
Humans
Lidocaine
Middle Aged
Patient Satisfaction
Skin Aging
temple area
Treatment Outcome
Title Correction of temporal wasting using calcium hydroxylapatite with integral lidocaine: An underused procedure for enhancing overall facial appearance
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjocd.13505
https://www.ncbi.nlm.nih.gov/pubmed/32441877
https://www.proquest.com/docview/2406308761
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9NAFB6FVkJcEDth0yC4gOUq3sY2tyoNqiqVHmhRb9Z4FiWSa0dNDIIDv4IfzHue8SRpCipcLGvk_X1--0LIWx0rrUWkfBlr5cdZoP1SR6HPBajXLFdxWGKB8_EndngWH50n54PBz_XqkmW5J35cW1fyP1SFNaArVsn-A2XdRWEB9oG-sAUKw_ZGNB7jaA3R63y2y1TlfeOLLpm5NRW1vBKz9sKbfpeYslJxzKFeKuOBtd0iKq-aSZBq2HXUeAqxtuyyXSjsIgAiTmKcoesOXk-xQwemSn9Fd1aFE3vQ687nc_hpHIa29V3RLC6wYtKTKAyWG-58E_WYdWPAvc9TNau4N95b90iEwZpHwjDROI38MLDxFrW-ZuZC9Jw3HG0hzLBRy6CNQDZTWf7E6hshcXbHKFkJtD6If0XOuexDZ_fAuUV37i2yG4KZAXxy9-TLZHLg4lBp3s3AcG9kG9x2uWDuzpsqzZadsmn2dHrL6T1y1xKA7hv03CcDVT8gt49tSsVD8msFItpo2oOIWhDRDkTUgoheARFFENEeRNSB6APdr6mDEHUQogAh6iBELYSogRBdQegROfs4OR0f-nZUhy-iME98ycqAZSwJWClkyjPJmARjIBegEfJMqBHXOYtFksdJoPNUhlyD6RHFMmR5IjmLHpOduqnVU0LLUguRMhzcir4blTNgHkkqI52JMtHpkLzrv3YhbB97HKdSFdt0HZI37ti56d5y7VGve6IVwFwxYsZr1bSLAtVdbJnJgiF5YqjprgOWSBxkKTzP-468f7lBcXQyPuj2nt3ogZ6TO6v_6gXZWV626iXovsvylQXob3mRuFo
linkProvider Ovid
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Correction+of+temporal+wasting+using+calcium+hydroxylapatite+with+integral+lidocaine%3A+An+underused+procedure+for+enhancing+overall+facial+appearance&rft.jtitle=Journal+of+cosmetic+dermatology&rft.au=Barbarino%2C+Sheila+C.&rft.date=2021-01-01&rft.issn=1473-2130&rft.eissn=1473-2165&rft.volume=20&rft.issue=1&rft.spage=62&rft.epage=66&rft_id=info:doi/10.1111%2Fjocd.13505&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_jocd_13505
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1473-2130&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1473-2130&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1473-2130&client=summon